Literature DB >> 10619632

Serotonin laterality in amygdala predicts performance in the elevated plus maze in rats.

S L Andersen1, M H Teicher.   

Abstract

Behavior in the elevated plus maze was correlated with hemispheric asymmetries in neurotransmitter content in limbic brain regions assayed with HPLC-EC in adult rats. A strong (r=0.86, p < 0.003) correlation exists between increased anxiety (more time spent in the closed arm) and the lateralization of serotonin in the amygdala. Greater serotonin in the right versus left amygdala relates to greater anxiety. In addition, increased dopamine in right prefrontal cortex is strongly correlated with anxiety (r=0.84, p < 0.01). No such correlations were observed for accumbens, hippocampus, or striatum. These data support the hypothesis that the right hemisphere is involved in emotional states: increased serotonin in the right amygdala is related to anxiety, while cortical dopamine may be associated with attention to the environment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619632     DOI: 10.1097/00001756-199911260-00006

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  18 in total

1.  Evoked activity in the hypothalamus and amygdala of the cat in conditions of food-related motivation and emotional tension.

Authors:  I V Pavlova; G L Vanetsian
Journal:  Neurosci Behav Physiol       Date:  2006-02

2.  Hemispheric differences in protein kinase C betaII levels in the rat amygdala: baseline asymmetry and lateralized changes associated with cue and context in a classical fear conditioning paradigm.

Authors:  R Orman; M Stewart
Journal:  Neuroscience       Date:  2006-11-22       Impact factor: 3.590

3.  Linkage of neuron spike activity in the right and left amygdala in food motivation and emotional tension.

Authors:  I V Pavlova
Journal:  Neurosci Behav Physiol       Date:  2006-03

4.  Kindling-induced changes in plasticity of the rat amygdala and hippocampus.

Authors:  Manja Schubert; Herbert Siegmund; Hans-Christian Pape; Doris Albrecht
Journal:  Learn Mem       Date:  2005 Sep-Oct       Impact factor: 2.460

5.  Memory enhancement induced by post-training intrabasolateral amygdala infusions of beta-adrenergic or muscarinic agonists requires activation of dopamine receptors: Involvement of right, but not left, basolateral amygdala.

Authors:  Ryan T Lalumiere; James L McGaugh
Journal:  Learn Mem       Date:  2005 Sep-Oct       Impact factor: 2.460

6.  Mapping cerebral blood flow changes during auditory-cued conditioned fear in the nontethered, nonrestrained rat.

Authors:  D P Holschneider; J Yang; T R Sadler; P T Nguyen; T K Givrad; J-M I Maarek
Journal:  Neuroimage       Date:  2005-10-10       Impact factor: 6.556

7.  Inactivation of the GATA Cofactor ZFPM1 Results in Abnormal Development of Dorsal Raphe Serotonergic Neuron Subtypes and Increased Anxiety-Like Behavior.

Authors:  Laura Tikker; Plinio Casarotto; Parul Singh; Caroline Biojone; T Petteri Piepponen; Nuri Estartús; Anna Seelbach; Ravindran Sridharan; Liina Laukkanen; Eero Castrén; Juha Partanen
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

8.  The effect of brain tumour laterality on anxiety levels among neurosurgical patients.

Authors:  A Mainio; H Hakko; A Niemelä; T Tuurinkoski; J Koivukangas; P Räsänen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

9.  Cerebellar Modulation of Mesolimbic Dopamine Transmission Is Functionally Asymmetrical.

Authors:  Zade R Holloway; Nick B Paige; Josiah F Comstock; Hunter G Nolen; Helen J Sable; Deranda B Lester
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

10.  Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice.

Authors:  Rhonda L Nelson; Zhihong Guo; Veerendra Madala Halagappa; Michelle Pearson; Audrey J Gray; Yasuji Matsuoka; Martin Brown; Bronwen Martin; Titilola Iyun; Stuart Maudsley; Robert F Clark; Mark P Mattson
Journal:  Exp Neurol       Date:  2007-02-13       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.